FDA.reportPublic FDA data

lenalidomide 20 MG Oral Capsule [Revlimid]

RxCUI
1429367
RxNorm name
lenalidomide 20 MG Oral Capsule [Revlimid]
Display name
lenalidomide 20 MG Oral Capsule [Revlimid]
Full name
lenalidomide 20 MG Oral Capsule [Revlimid]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RevlimidLENALIDOMIDECelgene Corporation5fa97bf5-28a2-48f1-8955-f56012d296be2023-03-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1429367

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5fa97bf5-28a2-48f1-8955-f56012d296beRevlimid 20 MG Oral Capsule [PSN] · lenalidomide 20 MG Oral Capsule [Revlimid] [SBD] · Revlimid 20 MG Oral Capsule [SY]340These highlights do not include all the information needed to use REVLIMID ® safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules, for oral use Initial U.S. Approval: 200520230324